Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis

Immunology of Schizophrenia

(2017) Norbert Müller   NEUROIMMUNOMODULATION

Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study

(2016) Peter S. Bloomfield et al.   AMERICAN JOURNAL OF PSYCHIATRY

Serum IL-4 and IL-10 Levels Correlate with the Symptoms of the Drug-Naive Adolescents with First Episode, Early Onset Schizophrenia

(2016) Şeref Şimşek et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Lipid peroxides as endogenous oxidants forming 8-oxo-guanosine and lipid-soluble antioxidants as suppressing agents

(2016) Kazuki Kanazawa et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Potential involvement of the interleukin-18 pathway in schizophrenia

(2016) Yong Xu et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Schizophrenia risk from complex variation of complement component 4

(2016) Aswin Sekar et al.   NATURE

Developmental timing and critical windows for the treatment of psychiatric disorders

(2016) Oscar Marín   NATURE MEDICINE

Oxidative Stress and DNA Damage in Untreated First-Episode Psychosis in Adolescents

(2016) Şeref Şimşek et al.   NEUROPSYCHOBIOLOGY

Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients

(2016) Kärt Kriisa et al.   Oxidative Medicine and Cellular Longevity

In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11C]DPA-713 PET and analysis of CSF and plasma

(2016) J M Coughlin et al.   Translational Psychiatry

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

(2015) B S Fernandes et al.   MOLECULAR PSYCHIATRY

May Non-antipsychotic Drugs Improve Cognition of Schizophrenia Patients?

(2015) M. Buoli et al.   PHARMACOPSYCHIATRY

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

(2015) Valeria Mondelli et al.   SCHIZOPHRENIA BULLETIN

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors

(2015) Tianyu Li et al.   PLoS One

The neurobiology and treatment of first-episode schizophrenia

(2014) R S Kahn et al.   MOLECULAR PSYCHIATRY

Biological insights from 108 schizophrenia-associated genetic loci

(2014)   NATURE

Imaging Neuroinflammation in Gray and White Matter in Schizophrenia: An In-Vivo PET Study With [18F]-FEPPA

(2014) M. Kenk et al.   SCHIZOPHRENIA BULLETIN

Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study

(2014) Mónica Martínez-Cengotitabengoa et al.   SCHIZOPHRENIA RESEARCH

Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder

(2014) S G Fillman et al.   Translational Psychiatry

Neurobiology of Cognitive Remediation Therapy for Schizophrenia: A Systematic Review

(2014) Anders Lillevik Thorsen et al.   Frontiers in Psychiatry

Meta-Analysis of Oxidative Stress in Schizophrenia

(2013) Joshua Flatow et al.   BIOLOGICAL PSYCHIATRY

The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies

(2013) Ragy R. Girgis et al.   BIOLOGICAL PSYCHIATRY

Autoimmunity, Inflammation, and Psychosis: A Search for Peripheral Markers

(2013) Veerle Bergink et al.   BIOLOGICAL PSYCHIATRY

Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia

(2013) A. Carlo Altamura et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia

(2013) Xueqin Song et al.   PSYCHOPHARMACOLOGY

Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update

(2013) I. E. Sommer et al.   SCHIZOPHRENIA BULLETIN

Pro-/Anti-inflammatory Dysregulation in Patients With First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia

(2013) Borja García-Bueno et al.   SCHIZOPHRENIA BULLETIN

Serum and gene expression profile of cytokines in first-episode psychosis

(2012) Marco Di Nicola et al.   BRAIN BEHAVIOR AND IMMUNITY

Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia

(2012) Ilaria Palladino et al.   Journal of Neuroinflammation

Plasma antioxidant capacity is reduced in Asperger syndrome

(2012) Mara Parellada et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A review of anti-inflammatory agents for symptoms of schizophrenia

(2012) William R Keller et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neuropoietic cytokines in normal brain development and neurodevelopmental disorders

(2012) H.B. Stolp   MOLECULAR AND CELLULAR NEUROSCIENCE

Prenatal inflammation and neurodevelopment in schizophrenia: A review of human studies

(2012) Brian J. Miller et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies

(2012) G. M. Khandaker et al.   PSYCHOLOGICAL MEDICINE

Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study

(2012) David Fraguas et al.   SCHIZOPHRENIA RESEARCH

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

(2012) Charles L. Raison et al.   JAMA Psychiatry

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

(2011) Brian J. Miller et al.   BIOLOGICAL PSYCHIATRY

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study

(2011) Juan Antonio Micó et al.   BMC Psychiatry

Leptin and interleukin-6 alter the function of mesolimbic dopamine neurons in a rodent model of prenatal inflammation

(2011) Argel Aguilar-Valles et al.   PSYCHONEUROENDOCRINOLOGY

Outcome in early-onset schizophrenia revisited: Findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study

(2011) G. Paul Amminger et al.   SCHIZOPHRENIA RESEARCH

Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies

(2010) Alan S. Brown et al.   AMERICAN JOURNAL OF PSYCHIATRY

Neuroprotective Effects of Cognitive Enhancement Therapy Against Gray Matter Loss in Early Schizophrenia

(2010) Shaun M. Eack et al.   ARCHIVES OF GENERAL PSYCHIATRY

Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain

(2010) Silvia Alboni et al.   BRAIN BEHAVIOR AND IMMUNITY

Baseline profiles of adolescent vs. adult-onset first-episode psychosis in an early detection program

(2009) I. Joa et al.   ACTA PSYCHIATRICA SCANDINAVICA

Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study

(2009) J. Doorduin et al.   JOURNAL OF NUCLEAR MEDICINE

Biomarkers in psychiatry

(2009) Ilina Singh et al.   NATURE

Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: Implications for altered one-carbon metabolism

(2009) Anvita Kale et al.   PSYCHIATRY RESEARCH

The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia

(2008) Xue-Qin Song et al.   BIOLOGICAL PSYCHIATRY